Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25731-25740 Newer>

The Motley Fool August 27, 2007 Jack Uldrich	3M Offers a New View If 3M can continue to apply nanotechnology to its other existing products as successfully as it has done with window treatments, its substantial investment in nanotechnology research and development will soon offer investors a clearer view of the company's long-term potential.
The Motley Fool August 27, 2007 David Lee Smith	BP Dances With Bears Russia is likely to use its newfound energy muscle to boost its status and power in the world community. For smart investors, it likely means that BP becomes slightly less compelling as an energy investment.
The Motley Fool August 27, 2007 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Wachovia... TD Bank... KMG Chemicals... American Software...
The Motley Fool August 27, 2007 Rich Smith	Foolish Forecast: Change at Energy Conversion Devices The alternative energy technology company is set to report its fiscal fourth-quarter 2007 earnings. Investors, here is what you can expect to see.
The Motley Fool August 27, 2007 Anders Bylund	Foolish Forecast: OmniVision's Stale Fruitcake The digital imaging expert is set to report its first-quarter earnings. Investors, here is what you can expect to see.
The Motley Fool August 27, 2007 Rick Aristotle Munarriz	Gateway: From Cow to Cowed The PC maker is wrapping up its troubled tenure as a stand-alone company, agreeing to be acquired by Taiwan's Acer in a $710 million deal that's more bitter than sweet.
The Motley Fool August 27, 2007 Brian Lawler	Neurochem Down for the Count? With likely two failed compounds - since the FDA rejected Neurochem's amyloidosis compound Kiacta a second time in July -- it's hard to see much value in shares of the company, considering its bare drug pipeline.
The Motley Fool August 27, 2007 Brian Orelli	Onyx: Old News Is Good News Onyx set a 52-week high today, even though the good news wasn't all that new. After the recent dearth of FDA approvals, investors may be flocking to a drug that's nearly certain to get the agency's thumbs-up.
The Motley Fool August 27, 2007 Tom Taulli	Mentor Graphics Gets Some Mercy The software company shows that its comeback hasn't flamed out. On a quarter-to-quarter basis, Mentor has shown lots of volatility over the years, giving investors whiplash.
The Motley Fool August 27, 2007 Brian Orelli	FDA's Burning Regulations New rules about sunscreen could shake up the way market share is divided now. The new requirements will begin in 2009 at the earliest. Until then, investors should listen to the earnings conference calls to keep track of how their companies are adapting.
<Older 25731-25740 Newer> Return to current articles.